News & Press Releases

  • 20 June 2017 - PRESS RELEASE

    Maximilian Muenchhoff has been honoured with the HIV/AIDS Research Award


    Some HIV-infected – and untreated children – who do not develop AIDS, control the virus in a different way from the few infected adults who remain disease-free. Dr Maximilian Muenchhoff, DZIF scientist at LMU´s Max von Pettenkofer Institute, has been honoured for characterizing the immunological mechanisms with the HIV/AIDS Research Award of the German Society of Infectious Diseases.more ]

  • 15 June 2017 - PRESS RELEASE

    Hector Award HIV goes to HPI scientists


    Prof Marcus Altfeld and Dr Angelique Hölzemer from the Heinrich Pette Institute (HPI) have been honoured with the "Hector Award HIV 2017”. Both scientists also work at the DZIF research field HIV. more ]

  • 06 June 2017 - PRESS RELEASE

    Myrcludex B: Priority for the new hepatitis D virus entry inhibitor


    The European Medicines Agency (EMA) has granted “PRIME eligibility” to Myrcludex B, and will provide priority support for its further drug development. The hepatitis B and D virus entry inhibitor was developed by DZIF scientists at the Heidelberg University Hospital.more ]

  • 30 May 2017 - PRESS RELEASE

    EU Commissioner visits HIPS


    Dr Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, visited the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) to inform himself about multidrug-resistant pathogens and the strategies used to fight them. Prof Rolf Müller, Director of the Institute, presented the research conducted in this field and illustrated how they are integrated into the German Center for Infection Research. more ]

  • 02 May 2017 - PRESS RELEASE

    Molecules directed against tumor cells patented


    Researchers at the ImmunoSensation cluster of excellence at the University of Bonn have managed to do what many scientists dream of: together with researchers from the USA, they have patented new molecules that allow the immune system to be directed against tumor cells. The license has already given the University of Bonn a first payment – and the scientists also gained a share.more ]

  • 18 April 2017 - PRESS RELEASE

    DZIF Prize for Translational Infection Research


    The DZIF Academy is pleased to open the call for application for the fourth DZIF Prize for Translational Infection Research. The German Center for Infection Research (DZIF) will award a prize of 5.000 Euro for exceptional translational infection research. The call is open to all infection researchers in Germany. Application Deadline: June 20, 2017.more ]

  • 13 April 2017 - PRESS RELEASE

    How an Ebola vaccine candidate activates our immune system

    EBOV 115

    In 2016, a clinical phase I trial on a potential vaccine against the dreaded Ebola virus was successfully completed. The tested vaccine “rVSV-ZEBOV” proved to be safe and effective. In a further trial, DZIF scientists from the University Medical Center Hamburg-Eppendorf (UKE) have now shown in detail how our immune systems react to the vaccine for the first time. This is an important step on the path to licensing a vaccine. more ]

  • 29 March 2017 - PRESS RELEASE

    New malaria prophylaxis promising in clinical trial


    Researchers from the University of Tübingen and the DZIF show medicine is effective when the timing is right. Their new active substance – DSM 265 – demonstrated a good prophylactic effect for Malaria. 21 healthy volunteers participated in the trial. The results have been published in the medical journal The Lancet Infectious Diseases.more ]

  • 09 March 2017 - PRESS RELEASE

    Memento Award 2017 goes to tropical disease specialists from Tübingen


    This year, the Memento Research Award for neglected diseases goes to Dr Carsten Köhler and Prof Peter Kremsner from the Institute of Tropical Diseases at the University Hospital Tübingen. With this, the jury honours their contributions to improving malaria treatment. more ]

  • 09 March 2017 - PRESS RELEASE

    Dampened immunity during pregnancy promotes evolution of more virulent flu


    During pregnancy, a mother’s immune system is suppressed to protect the fetus, which is perceived as a foreign body because it is genetically different. A partly DZIF funded study in mice found that suppressed immunity during pregnancy creates a window of opportunity for the H1N1 influenza virus to infect the mother and to rapidly, within a few days, mutate into a more virulent strain. The findings appear in Cell Host & Microbe on March 8.more ]

Results 21 to 30 of total 171